Biotechnology

CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million

HONG KONG and NANJING, China, Oct. 9, 2019 /PRNewswire/ -- Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program AI drug discovery collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceu...

2019-10-09 20:58 508

Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial

LONDON, MUMBAI, India and BAYREUTH, Germany, Oct. 9, 2019 /PRNewswire/ -- - RESILIENT Protocol captures Encyclopedic information from tumors and uses Artificial Intelligence (AI) to optimize treatments; - Objective Response and Disease Control Comparable to or better than most Immunotherapy opti...

2019-10-09 17:56 807

Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer

HANGZHOU, China and SHAOXING, China, Oct. 8, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Dr.Han...

2019-10-08 08:00 498

Cross-industrial technologies make a splash in Asia Agri-Tech Expo in Taipei

TAIPEI, Oct. 5, 2019 /PRNewswire/ -- The Asia Agri-Tech Expo & Forum 2019 will take place at Taipei Nangang Exhibition Center Hall 1 fromOctober 31 to November 2. Organised by Informa Markets of Taiwan Office (UBM Taiwan), the tradeshow features innovative, eco-friendly and sustainable manufac...

2019-10-05 10:06 370

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

Jeffrey D. Mowery Named Site Head/General Manager BOTHELL, Washington, Oct. 1, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment ofJeffery D. Mowery as Site Head/General Manager of theCopenhagen,...

2019-10-01 07:00 413

Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis

* Idiopathic pulmonary fibrosis (IPF) is a severe and fatal disease that causes lung damage and scarring * Blocking a protein called interleukin-11 (IL11), which is abnormally high in the lungs of patients with IPF, can reverse lung fibrosis and scarring in preclinical studies * Enleofen Bi...

2019-09-30 15:00 220

Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications

HANGZHOU, China, Sept. 25, 2019 /PRNewswire/ -- The preclinical results of AB-106 (original code: DS-6051b), an investigational next generation ROS1/NTRK dual inhibitor exclusively in-licensed by AnHeart Therapeutics, a wholly-owned subsidiary of Baoyuan Biopharmaceuticals Technology (Hangzhou) C...

2019-09-25 18:44 765

AGC Biologics Appoints New Site Head/General Manager of Chiba, Japan Operations

Naofumi Kagami Named Site Head/General Manager  BOTHELL, Washington, Sept. 25, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment ofNaofumi Kagami as Site Head/General Manager of theChiba, Japan fa...

2019-09-25 01:42 1119

Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market

High investment in adult immunization and innovations in DNA vaccines will rejuvenate the vaccines market, finds Frost & Sullivan SANTA CLARA, California, Sept. 24, 2019 /PRNewswire/ -- The need for improved immunogenicity, delivery technologies and reliable supply are driving the shift from the...

2019-09-24 23:28 1092

binx health Announces First Patients Benefiting From Single-Visit Test and Treatment for Chlamydia and Gonorrhea

binx FDA-cleared platform already impacting human health-poised to transform care for millions BOSTON, Sept. 23, 2019 /PRNewswire/ -- binx health, the pioneer in anywhere, anytime testing for women's health, today announced the first real-world use of the binxio platform, delivering same-visit d...

2019-09-23 20:30 916

2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors

SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced results from the microsatellite instability high/deficient mismatch repair (MSI-H/dMMR) solid tumor cohort in the GEMSTONE-101 Phase Ib study of the Company's investigation...

2019-09-22 14:22 840

2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab

SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced preliminary results from the Phase Ia trial of the Company's anti-CTLA-4 antibody in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Onco...

2019-09-22 13:39 980

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019

HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2019-09-20 19:00 11345

Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic Cooperation

BROOKLINE, Massachusetts, Sept. 19, 2019 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, and China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM) today announced the execution of ...

2019-09-19 23:12 1406

Taiwan Medical Professionals Assisting Malaysian Patients Rediscover Their Confidence and Rediscover Life

KUALA LUMPUR, Malaysia, Sept. 19, 2019 /PRNewswire/ -- Taiwan's medical care is renowned for its high quality, advanced technology, professionalism and affordable pricing. In fact, the cost of medical treatment inTaiwan is typically one-fifth of comparable services inEurope and the US. To further...

2019-09-19 14:05 1145

Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection

PLYMOUTH MEETING, Pennsylvania, Sept. 17, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that the company and its collaborator The Wistar Institute have received a$4.6 million National Institutes of Health (NIH) grant in support of innovative research to tackle a...

2019-09-17 21:00 1347

Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins Using Mass Spectrometry

STOCKHOLM, Sept. 16, 2019 /PRNewswire/ -- Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid ...

2019-09-16 16:01 1183

AdAlta secures licensing deal for the i-body platform with global medical technology and diagnostics firm, GE Healthcare

Highlights * AdAlta secures commercial agreement for its i-body platform with global medical technology and diagnostics firm, GE Healthcare. * Under the licensing deal, the two companies will develop i-bodies for diagnostic imaging. * AdAlta will screen its novel i-body library on a number ...

2019-09-16 15:44 1194

ZEISS to showcase advancements in digital and surgical technology at ESCRS 2019

New digital and industry first solutions from ZEISS will be presented at the European Society of Cataract and Refractive Surgery (ESCRS) fromSeptember 14 - 18, 2019 PARIS, Sept. 14, 2019 /PRNewswire/ -- During the 2019 European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting in...

2019-09-14 13:00 1562

CROMSOURCE Consolidates Its Hybrid Services Model

VERONA, Italy, Sept. 12, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), has announced consolidation of its Hybrid Services Model.  Due to client demand, CROMSOURCE has further refined its Hybrid Services to be able to provide its pharmaceutical, medical de...

2019-09-12 22:18 2152
123456 ... 53